We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+12.54%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.79B
AUM Growth
+$28.8M
Cap. Flow
-$185M
Cap. Flow %
-6.63%
Top 10 Hldgs %
33.01%
Holding
105
New
22
Increased
19
Reduced
24
Closed
16

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$27.9M
2
A icon
Agilent Technologies
A
+$26.2M
3
ELV icon
Elevance Health
ELV
+$21M
4
CRL icon
Charles River Laboratories
CRL
+$15.9M
5
DXCM icon
DexCom
DXCM
+$14.9M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$83.8M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$75.6M
3
AXSM icon
Axsome Therapeutics
AXSM
+$33.9M
4
VEEV icon
Veeva Systems
VEEV
+$33.4M
5
NVRO
NEVRO CORP.
NVRO
+$26.3M

Sector Composition

Rank Sector Weight
1 Healthcare 81.16%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVAX
26
DELISTED
Dynavax Technologies
DVAX
$40.5M 1.45%
3,805,370
– –
MCK icon
27
McKesson
MCK
$96.8B
$39.7M 1.42%
105,811
– –
ARGX icon
28
argenx
ARGX
$52B
$39.7M 1.42%
104,732
– –
EW icon
29
Edwards Lifesciences
EW
$51.1B
$39.5M 1.42%
530,030
+49,774
+10% +$3.84M
AZN icon
30
AstraZeneca
AZN
$245B
$39.1M 1.4%
288,400
– –
UNH icon
31
CALL
UnitedHealth
UNH
$377B
$36.9M 1.32%
+69,600
New +$36.9M
ELV icon
32
Elevance Health
ELV
$83B
$34.4M 1.23%
67,115
+41,315
+160% +$21M
TMO icon
33
Thermo Fisher Scientific
TMO
$213B
$34.2M 1.23%
62,143
– –
AVTR icon
34
Avantor
AVTR
$9.25B
$33.9M 1.21%
1,607,612
-472,045
-23% -$9.77M
PNT
35
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$33.8M 1.21%
4,633,802
+118,586
+3% +$880K
WAT icon
36
Waters Corp
WAT
$36.8B
$32.4M 1.16%
94,624
-23,010
-20% -$7.28M
BMRN icon
37
BioMarin Pharmaceuticals
BMRN
$11.6B
$32.1M 1.15%
310,401
-805,548
-72% -$75.6M
ISRG icon
38
Intuitive Surgical
ISRG
$135B
$30.4M 1.09%
+114,450
New +$27.9M
CRBU icon
39
Caribou Biosciences
CRBU
$149M
$28M 1%
4,459,783
-1,540,217
-26% -$13.7M
A icon
40
Agilent Technologies
A
$39.5B
$27.5M 0.98%
+183,504
New +$26.2M
KRTX
41
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$25.6M 0.92%
130,293
– –
BMRN icon
42
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
$25.1M 0.9%
243,000
+63,000
+35% +$5.91M
BCRX icon
43
BioCryst Pharmaceuticals
BCRX
$2.24B
$24.8M 0.89%
2,162,411
– –
SGEN
44
DELISTED
Seagen Inc. Common Stock
SGEN
$24.7M 0.89%
192,384
-172,831
-47% -$22.3M
JNJ icon
45
Johnson & Johnson
JNJ
$613B
$24.3M 0.87%
137,746
– –
AXSM icon
46
CALL
Axsome Therapeutics
AXSM
$10.9B
$23.1M 0.83%
+299,000
New +$17.9M
HCA icon
47
HCA Healthcare
HCA
$88B
$22.1M 0.79%
91,945
-83,290
-48% -$18.7M
PRCT icon
48
Procept Biorobotics
PRCT
$1.05B
$21.5M 0.77%
517,526
– –
ERAS icon
49
Erasca
ERAS
$6.19B
$20.7M 0.74%
4,797,460
-2,467,521
-34% -$16.7M
JAZZ icon
50
PUT
Jazz Pharmaceuticals
JAZZ
$15.8B
$20.5M 0.73%
+128,500
New +$18.8M
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q4 2022 Portfolio in Review

As of Q4 2022, PFM Health Sciences held 105 positions worth $2.79B, up 1% from $2.76B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

PFM Health Sciences withdrew a net $185M in Q4 2022, closing 16 positions and reducing 24 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $83.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 89% a quarter earlier, followed by Financials.

Against the trend, PFM Health Sciences opened a new position in Intuitive Surgical worth $30.4M.

  • PFM Health Sciences's largest Q4 2022 buy was Intuitive Surgical: 114,450 shares worth $30.4M.
  • PFM Health Sciences added most to Elevance Health in Q4 2022, an estimated $21M increase.
  • PFM Health Sciences's biggest Q4 2022 reduction was BioMarin Pharmaceuticals, cutting an estimated $75.6M.
  • PFM Health Sciences fully exited Jazz Pharmaceuticals in Q4 2022, selling an estimated $83.8M.
  • PFM Health Sciences's ten largest holdings make up 33% of its $2.79B portfolio in Q4 2022.
  • PFM Health Sciences opened 22 new positions and closed 16 in Q4 2022.
  • PFM Health Sciences's portfolio value rose 1% quarter-over-quarter to $2.79B.

Based on PFM Health Sciences's 13F filing for Q4 2022, filed 14 Feb 2023.